Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.50 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.34 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.33 |
| ▸ | USP2 | O75604 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | PRKCA | P17252 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2283062 | 1.00 | LPAR3 (0.50) | LPAR3LPAR2TSHRMAPTABCC4 | |
| SCHEMBL2281602 | 1.00 | LPAR3 (0.50) | LPAR3LPAR2TSHRMAPTABCC4 | |
| SCHEMBL9806045 | 1.00 | LPAR3 (0.50) | LPAR3LPAR2TSHRMAPTABCC4 | |
| SCHEMBL2285243 | 1.00 | LPAR3 (0.50) | LPAR3LPAR2TSHRMAPTABCC4 | |
| SCHEMBL2280949 | 1.00 | LPAR3 (0.50) | LPAR3LPAR2TSHRMAPTABCC4 | |
| SCHEMBL2285978 | 1.00 | LPAR3 (0.50) | LPAR3LPAR2TSHRMAPTABCC4 | |
| SCHEMBL95154 | 0.98 | — | — | |
| Water SCHEMBL28134103 | 0.95 | LPAR3 (0.45) | LPAR3LPAR2TSHRMAPTABCC4 | |
| SCHEMBL96095 | 0.90 | — | — | |
| SCHEMBL2283394 | 0.82 | ALDH1A1 (0.32) | TSHRALDH1A1CYP3A4CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7994273-B2 | Photoactive materials | ROLIC AG (CH) | 2011-08-09 | — | — | US | claimed |
| US-7750185-B2 | Photoactive materials | ROLIC AG (CH) | 2010-07-06 | — | — | US | claimed |
| US-7491752-B2 | Photoactive materials | ROLIC AG (CH) | 2009-02-17 | — | — | US | claimed |
| US-7034098-B2 | POlyimide, polyamide; liquid crystals, opticsoptics | ROLIC AG (CH) | 2006-04-25 | — | — | US | claimed |
| US-20050288480-A1 | Liquid crystals adjustment layers containing diamine compound; polyamic acid or polyimides; crosslinked | ROLIC AG (CH) | 2005-12-29 | — | — | US | claimed |
| EP-1368411-B1 | PHOTOACTIVE POLYMER | ROLIC AG (CH) | 2005-07-06 | — | — | EP | claimed |
| EP-1525182-A1 | PHOTOACTIVE MATERIALS | Rolic AG (CH) | 2005-04-27 | — | — | EP | claimed |
| US-20040265742-A1 | Photoactive materials | ROLIC AG (CH) | 2004-12-30 | — | — | US | claimed |
| US-20040185215-A1 | Photoactive polymer based on polyimides, polyamic acids and esters characterised in that it contains as a side-chain a dendritic block incorporating photoactive groups at its surface; use as orientation layers for liquid crystals and in the construction of unstructured and structured optical elements | ROLIC AG (CH) | 2004-09-23 | — | — | US | claimed |
| EP-1409563-A1 | PHOTOACTIVE MATERIALS | Rolic AG (CH) | 2004-04-21 | — | — | EP | claimed |
| WO-2004013086-A1 | PHOTOACTIVE MATERIALS | ROLIC AG (CH) | 2004-02-12 | — | — | WO | claimed |
| EP-1386910-A1 | Photoactive materials | Rolic AG (CH) | 2004-02-04 | — | — | EP | claimed |
| WO-2003008472-A1 | PHOTOACTIVE MATERIALS | ROLIC AG (CH) | 2003-01-30 | — | — | WO | claimed |
| EP-1277770-A1 | Photoactive materials | Rolic AG (CH) | 2003-01-22 | — | — | EP | claimed |
| EP-1229066-A1 | Photoactive polymer | Rolic AG (CH) | 2002-08-07 | — | — | EP | claimed |
| CN-104619709-B | Imidazopyridine derivatives as modulators of TNF activity | UCB生物制药私人有限公司 | 2016-11-09 | — | — | CN | disclosed |
| CN-104619709-A | Imidazopyridine derivatives as modulators of TNF activity | UCB PHARMA SA | 2015-05-13 | — | — | CN | disclosed |
| WO-2000059966-A1 | PHOTOACTIVE POLYMERS | ROLIC AG (CH) | 2000-10-12 | — | — | WO | disclosed |
| EP-1021479-A1 | PHOTOCROSSLINKABLE POLYIMIDES | Rolic AG (CH) | 2000-07-26 | — | — | EP | disclosed |
| WO-1999015576-A1 | PHOTOCROSSLINKABLE POLYIMIDES | ROLIC AG (CH) | 1999-04-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050288480-A1 | Liquid crystals adjustment layers containing diamine compound; polyamic acid or polyimides; crosslinked | C9, F12, DAO | LPAR3 2608/4885LPAR2 1629/4885TSHR 4654/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.